Site icon pigpork News, swine information

Indonesia-Japan explores potential partnerships on ASF vaccine R&D

Escrito por: porciNews Asia

Muhammad Muharram Hidayat (2nd from left), Imron Suandy (3rd from left), and the team of BBV Denpasar.

Indonesia’s Agriculture Ministry through its Main Veterinary Agency in Denpasar (BBV Denpasar) in Bali is open for partnerships with Japan on research and development of African swine fever (ASF) vaccine.

Until now, ASF is still a main challenge for the pig farming industry in Indonesia. This viral disease is not only impacting pig production in the country, but also causing huge economic losses for producers.

Therefore, a research and development of ASF vaccine is urgently needed. The vaccine is expected to help control the disease sustainably, strengthening the country’s national animal health system.

During his visit to BBV Denpasar, Agricultural Attaché of Indonesia’s government in Tokyo, Muhammad Muharram Hidayat, said Japanese government is committed to support partnerships on vaccine research with Indonesia. And he sees that BBV Denpasar has the capacity to become a research partner.

BBV Denpasar Head, Imron Suandy said his agency is ready to collaborate for ASF vaccine research and development.

“Our agency has professional human resources and a modern laboratory, including the plant tissue isolation method, to do research and development of ASF vaccine,” he added.

Importing ASF vaccine from Vietnam

In another development, Indonesia in May 2025 imported 120,000 doses of the Avac ASF live vaccine from Vietnam, following nearly three years of evaluation and testing in collaboration with Indonesian authorities.

According to Avac Vietnam, producer of the ASF vaccine, the vaccine was officially approved for use by Indonesia’s Agriculture Ministry in April 2025. The importer and distributor is Biotis Prima Agrisindo based in West Java province.

Nguyen Van Diep, General Director of Avac Vietnam, said the export underscores the vaccine’s quality and efficacy, having passed Indonesia’s stringent veterinary approval process. This milestone reflected not only the company’s success but also the progress of Vietnam’s veterinary vaccine sector in establishing a presence on the global stage.

Before receiving official circulation approval in Indonesia, the Avac ASF live vaccine underwent nearly three years of dossier evaluations and field trials, coordinated by the Indonesian Agriculture Ministry and the Faculty of Veterinary Medicine of IPB University. Trials conducted on 300 pigs confirmed that the vaccine is safe and highly effective in preventing ASF infections.

“The product’s success in passing rigorous testing procedures is a testament to the quality and effectiveness of Vietnamese domestic vaccines. We are confident that Avac ASF live vaccine is the most effective ASF vaccine available today, backed by the most extensive database of evaluations and real-world applications worldwide,” said Dr Diep.

Inspecting the ASF vaccine shipment before loading it onto the plane for export to Indonesia.

Exit mobile version